OCN
- Product code
- OCN
- Device name
- Insulin Autoantibody Kit
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.5660
- Medical specialty
- Immunology
- Marketing pathway
- 510(K)
- Flag
- Third-party review eligible
- 510(k) clearances (all years, FDA)
- 1 (all years; only the last 3 years are listed here)
FDA classification definition
The device is used for the semi-quantitative determination of insulin autoantibodies in human serum as an aid in the diagnosis of Type 1 diabetes mellitus (autoimmune mediated diabetes) in patients who have not received insulin therapy.
Official FDA classification page: OCN
Classification and pathway per current FDA publications. Data from openFDA (CC0).